Table 2 Clinicopathologic characteristics, COX-2 expression and TIL in comparison to recurrence ofnon-muscle invasive bladder carcinoma
Recurrent disease | |||
|---|---|---|---|
N=127 | Yes (n=78) | No (n=49) | P-value |
Gender | Cases (%) | Cases (%) | |
Male | 58 (74) | 36 (73) | 0.8834 |
Female | 20 (26) | 13 (27) | |
Age (years, median, range) | 71 (41 – 87) | 67 (54 – 78) | |
Tumor size: | Cases (%) | Cases (%) | |
> 3 cm | 40 (51) | 19 (39) | 0.1104 |
≤ 3 cm | 38 (49) | 30 (61) | |
Pathology: | Cases (%) | Cases (%) | |
PUNLMP† | 26 (38) | 28 (61) | 0.0258 |
LGPUC ‡ | 43 (62) | 18 (39) | |
Disease stage | Cases (%) | Cases (%) | |
Ta | 26 (37) | 28 (61) | 0,0182 |
T1 | 46 (63) | 18 (39) | |
Median follow-up (months) | 13 | 75 | |
COX-2 score | Cases (%) | Cases (%) | |
0 | 27 (45) | 2 (5) | 0.0001 |
1 | 7 (12) | 9 (23) | 0.2196 |
2 | 26 (43) | 28 (72) | 0.0101 |
TILs* | Cases (%) | Cases (%) | |
No | 32 (53) | 12 (26) | 0.009 |
Yes | 29 (47) | 35 (74) | |